ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 2671 - 2685 of 5996 products
Suzhou GeneQuantum Collaborates with MITRO on ADC Candidates
$5.00
Available
Qiming to Raise $250 Million for Second US Dollar Healthcare Fund
$5.00
Available
I-Mab Signs Collaboration MOU with Hong Kong's Bio-Cancer Treatment
$5.00
Available
Hua Starts US Trial of Lead Type 2 Diabetes Treatment, a GKA Activator
$5.00
Available
Health Hope, an AI Healthcare Company, Completes $15 Million A Round
$5.00
Available
Lyndra Raises $55 Million for Long-Acting Drug Delivery; HOPU Participates
$5.00
Available
Innovent Filing for Approval of Avastin Biosimilar is Accepted in China
$5.00
Available
China Medical System Pays $11 Million for 77% Stake in UK's Midatech
$5.00
Available
CStone to Start China Trial of FGFR4 Inhibitor for Liver Cancer
$5.00
Available
CARsgen Cleared to Start China Trials of CAR-T Liver Cancer Treatment
$5.00
Available
Advent Makes Majority Investment in BioDuro, a US-China CRO
$5.00
Available
I-Mab Approved to Start US Trials of Immunotherapy, its Third US Approval This Month
$5.00
Available
China to Start Shanghai NASDAQ-like Exchange for Young Tech Companies
$5.00
Available
Circassia Enter $35.7 Million Deal for US/China Rights to Neo-Natal Drug
$5.00
Available
Merck CEO: China Will Have a Top 50 Biopharma Company
$5.00
Available